Genome-Wide Association Study of L-Arginine and Dimethylarginines Reveals Novel Metabolic Pathway for Symmetric Dimethylarginine
Standard
Genome-Wide Association Study of L-Arginine and Dimethylarginines Reveals Novel Metabolic Pathway for Symmetric Dimethylarginine. / Lüneburg, Nicole; Lieb, Wolfgang; Zeller, Tanja; Chen, Ming-Huei; Maas, Renke; Carter, Angela M; Xanthakis, Vanessa; Glazer, Nicole L; Schwedhelm, Edzard; Seshadri, Sudha; Ikram, M Arfan; Longstreth, W T; Fornage, Myriam; König, Inke R; Loley, Christina; Ojeda Echevarria, Francisco Miguel; Schillert, Arne; Wang, Thomas J; Sticht, Heinrich; Kittel, Anja; König, Jörg; Benjamin, Emelia J; Sullivan, Lisa M; Bernges, Isabel; Anderssohn, Maike; Ziegler, Andreas; Gieger, Christian; Illig, Thomas; Meisinger, Christa; Wichmann, H-Erich; Wild, Philipp S; Schunkert, Heribert; Psaty, Bruce M; Wiggins, Kerri L; Heckbert, Susan R; Smith, Nicholas; Lackner, Karl; Lunetta, Kathryn L; Blankenberg, Stefan; Erdmann, Jeanette; Münzel, Thomas; Grant, Peter J; Vasan, Ramachandran S; Böger, Rainer H.
in: CIRC-CARDIOVASC GENE, 21.09.2014.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Genome-Wide Association Study of L-Arginine and Dimethylarginines Reveals Novel Metabolic Pathway for Symmetric Dimethylarginine
AU - Lüneburg, Nicole
AU - Lieb, Wolfgang
AU - Zeller, Tanja
AU - Chen, Ming-Huei
AU - Maas, Renke
AU - Carter, Angela M
AU - Xanthakis, Vanessa
AU - Glazer, Nicole L
AU - Schwedhelm, Edzard
AU - Seshadri, Sudha
AU - Ikram, M Arfan
AU - Longstreth, W T
AU - Fornage, Myriam
AU - König, Inke R
AU - Loley, Christina
AU - Ojeda Echevarria, Francisco Miguel
AU - Schillert, Arne
AU - Wang, Thomas J
AU - Sticht, Heinrich
AU - Kittel, Anja
AU - König, Jörg
AU - Benjamin, Emelia J
AU - Sullivan, Lisa M
AU - Bernges, Isabel
AU - Anderssohn, Maike
AU - Ziegler, Andreas
AU - Gieger, Christian
AU - Illig, Thomas
AU - Meisinger, Christa
AU - Wichmann, H-Erich
AU - Wild, Philipp S
AU - Schunkert, Heribert
AU - Psaty, Bruce M
AU - Wiggins, Kerri L
AU - Heckbert, Susan R
AU - Smith, Nicholas
AU - Lackner, Karl
AU - Lunetta, Kathryn L
AU - Blankenberg, Stefan
AU - Erdmann, Jeanette
AU - Münzel, Thomas
AU - Grant, Peter J
AU - Vasan, Ramachandran S
AU - Böger, Rainer H
PY - 2014/9/21
Y1 - 2014/9/21
N2 - BACKGROUND: -Dimethylarginines (DMA) interfere with nitric oxide (NO) formation by inhibiting NO synthase (asymmetric dimethylarginine, ADMA) and L-arginine uptake into the cell (ADMA and symmetric dimethylarginine, SDMA). In prospective clinical studies ADMA has been characterized as a cardiovascular risk marker whereas SDMA is a novel marker for renal function and associated with all-cause mortality after ischemic stroke. The aim of the current study was to characterise the environmental and genetic contributions to inter-individual variability of these biomarkers.METHODS AND RESULTS: -This study comprised a genome-wide association analysis of 3 well-characterized population-based cohorts (FHS (n=2992), GHS (n=4354) and MONICA/KORA F3 (n=581)) and identified replicated loci (DDAH1, MED23, Arg1 and AGXT2) associated with the inter-individual variability in ADMA, L-arginine and SDMA. Experimental in-silico and in-vitro studies confirmed functional significance of the identified AGXT2 variants. Clinical outcome analysis in 384 patients of the Leeds stroke study demonstrated an association between increased plasma levels of SDMA, AGXT2 variants and various cardiometabolic risk factors. AGXT2 variants were not associated with post-stroke survival in the Leeds study, nor were they associated with incident stroke in the CHARGE consortium.CONCLUSIONS: -These GWAS support the importance of DDAH1 and MED23/Arg1 in regulating ADMA and L-arginine metabolism, respectively, and identify a novel regulatory renal pathway for SDMA by AGXT2. AGXT2 variants might explain part of the pathogenic link between SDMA, renal function, and outcome. An association between AGXT2 variants and stroke is unclear and warrants further investigation.
AB - BACKGROUND: -Dimethylarginines (DMA) interfere with nitric oxide (NO) formation by inhibiting NO synthase (asymmetric dimethylarginine, ADMA) and L-arginine uptake into the cell (ADMA and symmetric dimethylarginine, SDMA). In prospective clinical studies ADMA has been characterized as a cardiovascular risk marker whereas SDMA is a novel marker for renal function and associated with all-cause mortality after ischemic stroke. The aim of the current study was to characterise the environmental and genetic contributions to inter-individual variability of these biomarkers.METHODS AND RESULTS: -This study comprised a genome-wide association analysis of 3 well-characterized population-based cohorts (FHS (n=2992), GHS (n=4354) and MONICA/KORA F3 (n=581)) and identified replicated loci (DDAH1, MED23, Arg1 and AGXT2) associated with the inter-individual variability in ADMA, L-arginine and SDMA. Experimental in-silico and in-vitro studies confirmed functional significance of the identified AGXT2 variants. Clinical outcome analysis in 384 patients of the Leeds stroke study demonstrated an association between increased plasma levels of SDMA, AGXT2 variants and various cardiometabolic risk factors. AGXT2 variants were not associated with post-stroke survival in the Leeds study, nor were they associated with incident stroke in the CHARGE consortium.CONCLUSIONS: -These GWAS support the importance of DDAH1 and MED23/Arg1 in regulating ADMA and L-arginine metabolism, respectively, and identify a novel regulatory renal pathway for SDMA by AGXT2. AGXT2 variants might explain part of the pathogenic link between SDMA, renal function, and outcome. An association between AGXT2 variants and stroke is unclear and warrants further investigation.
U2 - 10.1161/CIRCGENETICS.113.000264
DO - 10.1161/CIRCGENETICS.113.000264
M3 - SCORING: Journal article
C2 - 25245031
JO - CIRC-CARDIOVASC GENE
JF - CIRC-CARDIOVASC GENE
SN - 1942-325X
ER -